Magellan Health (NASDAQ: MGLN) recently received a number of ratings updates from brokerages and research firms: 2/27/2019 – Magellan Health was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Magellan Health's shares have outperformed S&P 500’s gain year-to-date. Its rising top line impresses. Several strategic […]